BioNexus Gene Lab Corp. (BGLC) Shareholders’ equity 2018–2025
BioNexus Gene Lab Corp. (BGLC) shareholders’ equity at each fiscal year-end, per SEC filings.
$8.6MFY2025 · since FY2018: $1.5M → $8.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $8.6M | +3.5% |
| FY2024 | $8.3M | -13.8% |
| FY2023 | $9.7M | +44.9% |
| FY2022 | $6.7M | -7.2% |
| FY2021 | $7.2M | +7.8% |
| FY2020 | $6.7M | +493.6% |
| FY2019 | $1.1M | -26.3% |
| FY2018 | $1.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice